REN and heart failure: Various pharmacotherapeutic agents conventionally used in the treatment of heart failure have been explored in randomised-controlled trials for the prevention of cardiac dysfunction, including inhibitors of the renin–angiotensin–aldosterone system and beta-blockers [44].